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The relationship between intake of soy products and death from stomach cancer was examined in a community-based
prospective study of Japanese men and women in Takayama, Japan. Over 7 years of follow-up, 121 deaths from stomach
cancer (81 men and 40 women) occurred among 30304 (13880 men and 16424 women) participants who were at least 35
years of age. Diet including the intake of soy products and isoﬂavones was assessed by a validated semiquantitative food–
frequency questionnaire at the beginning of the study. In men, the highest compared to the lowest tertile of total soy product
intake was signiﬁcantly inversely associated with death from stomach cancer after controlling for covariates (hazard
ratios=0.50; 95% conﬁdence intervals (CIs) 0.26-0.93, P for trend=0.03). Decreased hazard ratios for the highest compared to
the lowest tertiles of total soy product intake (hazard ratios=0.49; 95% CI 0.22–1.13) was observed in women, although this
association was of marginal signiﬁcance. These data suggest that soy intake may reduce the risk of death from stomach cancer.
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The anti-cancer properties of soy isoﬂavones, i.e., genistein and
daidzein, have been demonstrated in experimental studies (Adler-
creutz et al, 1995). Interest focussed initially on the effects of soy
isoﬂavones on hormone dependent cancers such as breast cancer
and prostate cancer, mainly because of their ability to bind to
the oestrogen receptor (Martin et al, 1978).
An inverse ecological correlation was reported between stomach
cancer deaths in 47 Japanese prefectures and intake of soy products
and isoﬂavones estimated from national nutritional survey data,
raising the possibility that soy has a potential preventive effect
against stomach cancer (Nagata, 2000). Certain analytic epidemio-
logical studies on soy intake and stomach cancer, as reviewed by
Messina et al (1994) and Wu et al (2000). However, soy intake
in relation to stomach cancer was not a primary objective of these
studies and only a limited number of soy-based items were covered
and the association of stomach cancer with intake of isoﬂavones or
soy products as a whole was not assessed.
We have investigated the relationship between soy intake and
subsequent death from stomach cancer among Japanese men and
women in a cohort study using a validated dietary questionnaire
that listed various types of soy foods. Analysis was done separately
for fermented and non-fermented soy products, because Wu et al
(2000) presented the pooled odds ratio/relative risk estimates sepa-
rately for these two catogories of soy products in a metaanalysis of
previous studies on soy intake and stomach cancer.
MATERIALS AND METHODS
The subjects were cohort members from the Takayama Study. The
methology of the Takayama Study has been described previously
(Shimizu, 1996). Brieﬂy, the cohort included a total of 14427
men and 17125 women from Takayama City, Gifu, Japan, who
were 35 years of age or older. Each participant completed a self-
administered questionnaire in 1992 that was used to collect demo-
graphic and general information about smoking, alcohol, diet,
exercise and medical and reproductive histories. The response rate
was about 90%. Those who had smoked a total of 20 or more
packs of cigarettes in their lifetime were deﬁned as smokers.
Dietary history was assessed using a 169-item semiquantitative
food-frequency questionnaire. Participants were asked to report
the average frequency with which food was consumed in the
previous year and the usual serving size of each food item. Nine
food items for speciﬁc soy products and some others with soy
products as ingredients were accounted for in order to estimate
the total intake of soy products. Thus, total soy product intake
was the sum of the intakes of tofu, miso, soybeans, natto, soymilk,
okara, dried-tofu, deep-fried tofu, fried-tofu, fried tofu and minced
vegetables/seaweed. The intake of foods and nutrients was esti-
mated from the frequency of ingestion and portion size using
the Japanese Standard Tables of Food Composition, 4th revised
edition, published by the Science and Technology Agency of Japan.
We also estimated the amounts for two main categories of soy
products: fermented and non-fermented soy products. The fermen-
ted category included miso and natto. The other soy foods
measured were non-fermented soy products. Isoﬂavone (daidzein
plus genistein) contents are higher in fermented soy products;
according to data summarised by Wakai et al (1999), isoﬂavone
concentration per 100 g were 76.6 mg for miso and 67.4 mg for
natto, while 24.1 mg for tofu and 36.2 mg for boiled soy beans.
Salt is rich in miso, around 10 g per 100 g. The other soy products
contain less than 1 g of salt per 100 g. Detailed information on the
questionnaire concerning validity and reproducibility tests has been
provided elsewhere (Shimizu et al, 1999; Nagata et al, 2001). For
example, the Spearman correlation coefﬁcients comparing estimates
from this questionnaire and 12 daily diet records over 1 year were
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www.bjcancer.com0.75, 0.77 and 0.74 for soy intake in terms of the total amount (g)
of soy products, daidzein, and genistein, respectively, in men.
Corresponding values for women were 0.68, 0.63, and 0.65, respec-
tively.
We excluded subjects who reported prevalent cancer (n=726;
186 men and 540 women) or a history of total/partial gastrectomy
(n=399; 361 men and 161 women) at the baseline. Thus, the result-
ing baseline population was 30304 (13880 men and 16424
women).
During 7 years of follow-up (1992–1999), deaths and their
causes occurring in Takayama City were conﬁrmed with data from
the ofﬁce of the National Vital Statistics. The Statistics and Infor-
mation Department of the Japanese Ministry of Health and welfare
obtain information on deaths and code the causes of death using
the International Classiﬁcation of Diseases (ICD). Permission to
review the data regarding dates and causes of deaths was obtained
from the Management and Coordination Agency, Japan. Stomach
cancer was considered to be the underlying cause of death when
the ICD-9 code was 151 or the ICD-10 code was C16. Information
concerning subjects who moved away from Takayama City during
the course of the study was obtained from the residential registers.
During the study period, 648 (4.6%) men and 536 (3.3%) women
moved out of Takayama City.
This study was approved by the local institutional review board.
To assess the association between soy intake and death from
stomach cancer and to adjust for potential confounding factors,
we computed hazard ratios (HRs) and their 95% conﬁdence inter-
vals (CIs) of stomach cancer death that occurred during the 7-year
study by using Cox proportional hazard models. The length of
follow-up was computed for each subject as the number of years
elapsed from the start of the study (September 1, 1992) until the
date of death due to stomach cancer, the date of death due to
any causes other than stomach cancer, the date on which the
person moved out of Takayama, or the end of the study (Decem-
ber 31, 1999). Food and nutrient intake was adjusted for total
energy by using the method proposed by Willett (1990) and were
converted into categorical variables based on the tertile of their
distribution among the entire study population at the baseline.
The lowest tertile was the reference category. Initial analysis exam-
ined the association between soy intake and death from stomach
cancer after controlling for age and total energy. To examine
whether the association of soy intake with stomach cancer death
could be attributed to non-dietary or dietary variables other than
soy product intake, the variables which were signiﬁcantly asso-
ciated with stomach cancer death were included in the models as
covariates. The variables examined as potential confounders
included marital status, body size, education, smoking and alcohol
history, history of chronic diseases, use of medication including
hormone replacement therapy, reproductive history and dietary
components other than soy product intake. Tests for trend were
performed on continuous variables using the median value on
the categories. All the statistical analyses were performed using
SAS programs (SAS Institute, Cary, NC, USA).
RESULTS
During 208951 person-years of follow-up over 7 years, 121 deaths
(81 men and 40 women) occurred due to stomach cancer. Charac-
teristics of participants by tertile of soy product intake are shown
in Table 1.
In men, there was a statistically signiﬁcant inverse association
between the intake of total soy products and the rate of death from
stomach cancer after controlling for age and total energy (Table 2).
The intake of non-fermented (but not fermented) soy products was
signiﬁcantly inversely associated with the death rate from stomach
cancer. Among non-dietary factors, smoking status and body mass
index at about 21 years of age were signiﬁcantly associated with the
rate of stomach cancer death after controlling for age; the HRs
(95% CI) for current and former smokers compared to those
who never smoked were 2.02 (1.07–3.80) and 1.18 (0.60–2.31),
respectively. The HR (95% CI) for the second and highest
compared to the lowest tertile of BMI at about 21 years of age were
2.05 (1.14–3.68) and 2.27 (1.22–4.20), respectively. After adjust-
ment for these variables, the inverse associations for total soy
product and non-fermented soy product intake remained statisti-
cally signiﬁcant.
For men, of the other dietary components that included total
protein, animal protein, vegetable protein, carbohydrate, carotene,
crude ﬁbre, salt, vitamin C, vitamin E, vegetables, fruits, rice,
processed meats, ﬁsh and shellﬁsh, dried ﬁsh, pickled vegetables,
coffee, and green tea, salt intake was signiﬁcantly inversely asso-
ciated with stomach cancer mortality (HR for the highest
compared to the lowest tertile=0.53; 95% CI (0.31–0.91)) and rice
intake was signiﬁcantly positively associated with stomach cancer
mortality (HR for the highest compared to the lowest tertile=1.81;
95% CI 1.06–3.08) after controlling for age and total energy.
Additional adjustment for the intake of salt and rice did not
substantially alter the results.
Intake of fermented soy products was not associated with the
death from stomach cancer. However, natto (but not miso) was
associated with a decreased risk of stomach cancer death
(HR=0.70 and 1.19 for the highest tertiles of natto and miso,
respectively) after controlling for non-dietary and dietary covari-
ates.
In women, the total amount of soy product intake was signiﬁ-
cantly inversely associated with death from stomach cancer after
controlling for age and total energy (Table 2). Among other dietary
and non-dietary variables measured, marital status, age at
menarche, BMI at about 21 years of age, and intake of caffeinated
coffee were signiﬁcantly associated with the rate of death from
stomach cancer after controlling for age: HR=2.15 for single
compared to married; HRs=0.51, 0.41, and 0.18, for age at
menarche 13–14, 15–16, and 17+ years compared to 5=12 years,
respectively; HR=3.36 and 2.16 for the second and the highest
compared to the lowest tertile of BMI at about 20 years of age;
HR=2.54 for daily compared to rare/never intake of caffeinated
coffee. Simultaneous adjustment for these variables did not
substantially alter the results. Both fermented and non-fermented
soy product intake was inversely associated with the rate of death
from stomach cancer, although the associations did not attain
statistical signiﬁcance. Miso intake was nonsigniﬁcantly but inver-
sely associated with stomach cancer death in women (HR=0.55,
95% CI 0.23–1.34 for the highest tertile).
We re-analysed data excluding stomach cancer death that
occurred during the ﬁrst 4 years (n=38) in men. The HR estimates
did not change substantially: HRs were 0.55, 1.15, and 0.54 for the
highest compared to the lowest tertile of total, fermented, and non-
fermented soy products, respectively.
DISCUSSION
We observed a signiﬁcantly reduced rate of death from stomach
cancer in the highest compared with the lowest tertile of total
soy product intake in men. In particular, a strong inverse associa-
tion was observed for non-fermented soy products in terms of both
the amount (g) and isoﬂavone intake (mg). A small number of
deaths from stomach cancer in women resulted in a lack of statis-
tical power to detect a signiﬁcant association between soy intake
and death from stomach cancer, but the magnitude of HR esti-
mates for the intake of total soy products were similar to that
observed for men. These data support the hypothesis that a high
intake of soy is associated with decreased risk of stomach cancer.
To our knowledge, this is the ﬁrst analytic epidemiologic study
on stomach cancer to estimate soy and isoﬂavone intake using a
validated questionnaire with a broad range of categories for soy
products. Among previous prospective studies on diet and stomach
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British Journal of Cancer (2002) 87(1), 31–36 ã 2002 Cancer Research UKcancer, six included one or two soy food items (Hirayama, 1984;
Nomura et al, 1990; Kato et al, 1992; Inoue et al, 1996; Ahn,
1997; Galanis et al, 1998). In a Japanese study, Hirayama (1984)
reported a signiﬁcantly reduced risk of stomach cancer death asso-
ciated with the daily intake of miso-soup (relative risk (RR)=0.74)
compared to those who answered ‘never/rare’. No signiﬁcant asso-
ciation between drinking miso soup and the risk of stomach cancer
was reported in other four studies (Kato et al, 1992; Inoue et al,
1996; Galanis et al, 1998). Another soy product, tofu, was included
in two studies. In a study of Japanese-American men reported by
Nomura et al (1990), the RR of stomach cancer was 0.7 (95%
CI 0.2–2.3) for those who ate tofu ﬁve times per week or more
compared to those who ate it one time or less each week. Another
study conducted in Korea showed a RR of 0.6 (95% CI 0.40–1.10)
for the highest quartile of tofu intake (Ahn, 1997). Most of
previous case–control studies included at most only two soy
products (miso/soy bean paste or tofu/bean curd) (Wu et al, 2000).
Wu et al (2000) conducted a meta-analysis of the association of
soy product intake with stomach cancer based on previous
prospective and case–control studies. They calculated the pooled
odds ratio/relative risk estimates separately for fermented and
non-fermented soy products. The analysis of 14 studies excluding
the study reported by Hirayama yielded an risk estimate of 1.26
(95% CI 1.11–1.43) in association with a high intake of fermented
soy products. In contrast, the risk estimate was 0.72 (95% CI 0.63–
0.82) for non-fermented soy product intake based on 10 studies.
However, they also observed the similar patterns in risk of stomach
cancer according to fermented soy product intake and salt intake in
these studies. The association of stomach cancer risk with non-
fermented soy products was similar to that with vegetables/fruit
intake in these studies. Salt and vegetable/fruit intake was directly
associated with stomach cancer risk. Therefore, they suggested the
possibility that the reported associations for fermented soy
products might be affected by the confounding effect of salt intake,
and the reported associations for non-fermented soy products
might be affected by confounding effects of vegetable/fruit intake.
In almost all of the studies in their review, the possible confound-
ing effects of salt, vegetables/fruits, and other dietary factors had
not been considered in the soy product analysis. Our study also
revealed a difference in the stomach cancer death rate for men
based on their consumption of fermented and non-fermented soy
products differently associated with the rate of stomach cancer
death in men. However, the results on the association between
non-fermented soy product intake and death from stomach cancer
were not altered after controlling for vegetable or fruit intake in
addition to the non-dietary and dietary covariates (for example,
after additional adjustment for vegetable intake, HR=0.49 (95%
CI 0.26–0.92 ) in men and HR=0.48 (95% CI 0.20–1.14) in
women for the highest compared to the lowest tertile). Additional
adjustment for total salt intake also did not alter the results for
fermented soy products (HR=0.55 (95% CI 0.23–1.33) for the
highest compared to the lowest tertile of intake in women; HR
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Table 1 Baseline characteristics of 13 880 men and 16 424 women
Men Women
Tertile of total soy product
intake
Tertile of total soy product
intake
Basic characteristics Low Middle High Low Middle High
Median soy product intake (g per day) 49.7 85.6 140.0 46.7 79.5 126.9
Mean age (years) 51.1 54.6 57.6 53.4 55.4 58.2
Mean body mass index (kg per m
2) 22.7 22.5 22.5 22.0 22.0 22.1
Mean BMI at age about 20 years (kg per m
2) 21.3 21.4 21.7 21.0 21.2 21.4
Mean alcohol intake (ml per day) 44.1 41.7 37.8 9.3 7.5 6.2
Mean exercise (METs
a×h per week) 25.9 27.1 26.7 17.5 19.4 18.6
Married (%) 90.0 91.8 92.5 72.1 76.2 74.5
Years of education 515 years (%) 13.9 10.7 9.6 5.2 4.9 3.7
Current smokers (%) 59.6 53.7 47.7 17.5 11.5 9.7
Former smokers (%) 25.1 30.1 34.1 5.1 4.4 4.1
Age at menarche 412 years (%) 14.8 12.9 9.7
Current users of oral contraceptives (%) 1.0 0.4 0.2
Current users of hormone replacement therapy (%) 1.6 1.7 1.9
Men Women
Selected dietary variables (mean+s.d.) (mean+s.d.)
Soy product intake (g per day)
Tofu 60.3+45.6 53.5+37.7
Miso 17.1+11.7 15.0+9.5
Soybeans 6.3+12.0 6.4+11.2
Natto 3.7+6.6 3.4+5.8
Fried tofu 2.2+4.3 2.3+4.3
Deep fried tofu 5.0+4.0 4.7+3.7
Dried tofu 0.3+0.7 0.3+0.8
Fried tofu and minced vegetables/seaweed 3.2+6.2 3.3+6.2
Okara 0.9+6.9 1.0+6.7
Soymilk 3.1+24.0 3.3+23.5
Total 102.1+72.5 93.3+64.0
Total energy (kcal per day) 2591+868 2103+779
Total protein (g per day) 94.3+37.5 82.0+33.9
Carbohydrate (g per day) 352+114 302+108
Total fat (g per day) 61.0+28.4 55.2+26.5
Salt (g per day) 14.3+6.2 13.1+5.8
Coffee (ml per day) 125+148 98+133
aMETs, metabolic equivalents.
Soy intake and stomach cancer death
C Nagata et al
33
ã 2002 Cancer Research UK British Journal of Cancer (2002) 87(1), 31–36for men are shown in Table 2). These results suggest the negative
association found between soy intake and stomach cancer death
is not due to confounding with salt or vegetable/fruit intake.
However, it is possible that other, non-measured factors, may
contribute to some potential confounding. The fact that miso
was negatively associated with stomach cancer death in women
and that the other fermented soy food, natto, was also negatively
associated with stomach cancer death in men, may suggest that
the ﬁnding for miso in men is due to confounding factors.
Japan remains among the countries showing the highest mortal-
ity rates from stomach cancer in the world. The Japanese diet in
Japan includes soybean-based foods that are rich in the isoﬂavones.
It could be argued that our ﬁndings contradict these observations.
The results from the present study imply that the high consump-
tion of soy in Japan should not contribute to its high mortality
rate from stomach cancer. We observed signiﬁcantly positive asso-
ciation between the consumption of rice and stomach cancer
mortality in men, and the association was marginally signiﬁcant
in women. High-starch diets have been hypothesised to be asso-
ciated with stomach cancer (Ji et al, 1998). High rice
consumption, which is common among the Japanese, may contri-
bute to their high mortality rate from stomach cancer in Japan.
An inverse association of dietary soy with stomach cancer is
biologically plausible. Isoﬂavones have been offered as the primary
anticancer soy constituent. Genistein inhibited the growth of
human gastric cancer cells (Yanagihara et al, 1993). Genistein atte-
nuated gastric carcinogenesis by inducing increased apoptosis and
lowering cell proliferation and angiogenesis of antral mucosa and
gastric cancers (Tatsuta et al, 1999). A diet containing miso inhib-
ited N-methyl-N'-nitro-N-nitrosoguanidine induced stomach
tumours (Kim et al, 1985; Watanabe et al, 1999). It is also possible
that other components in soy products might be etiologically
important agents. Several laboratory studies have demonstrated
that saponins as well as the Bowman–Birk Inhibitor isolated from
soybeans have anti-carcinogenic properties (von Hofe et al, 1991;
Rao and Sung, 1995).
Use of population-based design is one of advantages of the
present study. The response rate was high, and the number of
people who were censored because they moved out of the city
was small. We focused considerable attention on validating the
method used for dietary assessment with the use of food records.
Our questionnaire enabled us to estimate soy product intake quan-
titatively and to include careful adjustments for many potentially
confounding factors.
There are several limitations in the present study. We examined
the relation between soy intake and stomach cancer mortality, not
incidence. Thus, our results reﬂect the potential effect of soy intake
on stomach cancer incidence, survival, or both. If soy intake is
related differently to incidence than it is to mortality, our results
are potentially biased. For example, although the effect of gastric
cancer screening on survival is not clear, there is a possibility that
a high intake of soy might actually be associated with an increased
incidence of stomach cancer combined with a higher participation
rate in stomach cancer screening, which could lead to earlier diag-
nosis and better chances of survival. We obtained the information
on history of participation in stomach cancer screening at the base-
line but not during the follow-up period. Additional adjustment
for history of participation in stomach cancer screening for 3 years
prior to entry into the study did not alter the observed association
between soy intake and risk of death from stomach cancer. For
men, the HRs were 0.59 (95% CI 0.26–0.93), 1.05 (95% CI
0.56–1.96), 0.48 (95% CI 0.25–0.90), and 0.63 (95% CI 0.33–
1.21) for the highest compared to the lowest tertiles of total,
fermented and non-fermented soy products, and total isoﬂavones,
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Table 2 Hazard ratios (HRs) and 95% conﬁdence interval (CI) of stomach cancer death according to soy intake
Men Women
Tertile of soy product intake
P for
Tertile of soy product intake
P for
Low Middle High trend Low Middle High trend
Total soy products
Median intake (g per day)
a 49.7 85.6 140.0 46.7 79.5 126.9
No. of death from stomach cancer 29 33 29 16 15 9
No. of person years 31 656 31 428 31 196 38 201 38 428 38 041
HR (95% CI)
Age and energy adjusted 1.00 0.74 (0.44–1.24) 0.46 (0.27–0.81) 0.006 1.00 0.83 (0.41–1.69) 0.42 (0.19–0.95) 0.04
Adjusted
b 1.00 0.75 (0.45–1.26) 0.48 (0.27–0.83) 0.008 1.00 0.93 (0.45–1.90) 0.49 (0.21–1.12) 0.10
Adjusted
c 1.00 0.76 (0.44–1.31) 0.50 (0.26–0.93) 0.03 1.00 0.97 (0.47–1.99) 0.53 (0.23–1.22) 0.15
Fermented soy products
Median intake (g per day) 8.9 18.3 30.9 8.2 16.8 30.9
No. of death from stomach cancer 24 30 27 16 15 9
No. of person years 31 595 31 447 31 238 38 052 38 503 38 116
HR (95% CI)
Age and energy adjusted 1.00 1.15 (0.67–1.97) 0.89 (0.51–1.54) 0.15 1.00 0.75 (0.36–1.54) 0.49 (0.23–1.07) 0.07
Adjusted
b 1.00 1.17 (0.69–2.01) 0.91 (0.53–1.58) 0.76 1.00 0.78 (0.38–1.61) 0.52 (0.24–1.13) 0.10
Adjusted
c 1.00 1.26 (0.72–2.19) 1.05 (0.57–1.93) 0.84 1.00 0.83 (0.40–1.72) 0.56 (0.25–1.24) 0.16
Non-fermented soy products
Median intake (g per day) 36.7 65.2 112.0 35.3 61.2 102.0
No. of death from stomach cancer 29 29 23 15 16 9
No. of person years 31 716 31 385 31 178 38 211 38 373 38 087
HR (95% CI)
Age and energy adjusted 1.00 0.73 (0.43–1.22) 0.45 (0.26–0.79) 0.005 1.00 0.92 (0.46–1.86) 0.44 (0.19–1.00) 0.05
Adjusted
b 1.00 0.73 (0.44–1.23) 0.46 (0.26–0.81) 0.006 1.00 0.97 (0.48–1.96) 0.48 (0.21–1.10) 0.09
Adjusted
c 1.00 0.74 (0.43–1.28) 0.49 (0.26–0.92) 0.03 1.00 1.01 (0.50–2.04) 0.51 (0.22–1.18) 0.13
aAdjusted for total energy.
bMen: adjusted for age, total energy, smoking status (current, former, and never-smokers) and body mass index at age about 21 years; Women:
adjusted for age, total energy, marital status, age at menarche, and body mass index at age about 21 years.
cMen: adjusted for the variables above and intake of salt and
rice; Women: adjusted for the variables above and intake of coffee.
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0.23–1.20), 0.57 (95% CI 0.27–1.22), 0.58 (95% CI 0.26–1.30),
and 0.54 (95% CI 0.23–1.27), respectively.
The prospective design of our study and exclusion of those with
cancer and gastrectomy at the baseline lessen the possibility that
disease status would bias the reporting of exposures. However,
disease history obtained at the baseline was based on self-reporting.
Those who reported a history of gastric ulcer may have been not
informed that they actually had gastric cancer. When we re-
analysed data excluding those who had reported a history of gastric
ulcer (2041 men), however, the results were not altered substan-
tially. The HRs (95% CI) were 0.50 (0.26–0.97), 1.13 (0.59–
2.14), 0.47 (0.24–0.91), and 0.67 (0.34–1.29) for the highest as
compared to the lowest tertiles of total, fermented and non-
fermented soy products, and total isoﬂavones, respectively. We also
tried to avoid the possibility that underlying stomach cancer
should affect the diet by re-analysing data excluding deaths from
stomach cancer that occurred during the ﬁrst 4 years of the study.
The relatively short follow-up was also limitation. Fatal cases
that progressed from diagnosis to death in 7 years or less may
not have been representative of all stomach cancer cases, or even
all stomach cancer deaths.
Adjustment for potential confounders did not modify the HR
estimates. However, the high colinearity between various nutrients,
foods, and food groups make it difﬁcult to distinguish among the
effects.
We could not obtain information on a history of infection
with Helicobacter pylori, a major risk factor for stomach cancer.
Intake of tofu was signiﬁcantly inversely associated with H. pylori
infection in a cross-sectional study of Japanese men (Shinchi et
al, 1997). This study found no association of miso soup intake
with H. pylori infection, but in another cross-sectional study of
Japanese men (Tsugane et al, 1994), miso soup intake was signif-
icantly positively associated with H. pylori infection. High dose of
genistein reduced H. pylori toxin-induced inﬂammatory cytokine
expression (interleukin-8) (Ding et al, 1997). Genistein inhibited
growth of H. pylori (Bae et al, 2001). Infection of H. pylori
may be a potential confounding factor or a marker of certain
confounding factor for the association between soy product intake
and stomach cancer. It is also possible that H. pylori infection is
an intermediate factor between soy product intake and stomach
cancer.
Our questionnaire was designed to measure an individual’s rela-
tive intake of food and nutrients rather than their absolute values.
The data presented for food and nutrient intake may have been
overestimated by the questionnaire. In the validity study, the esti-
mates for soy product intake were about 20% higher for men and
40% higher for women when they were based on the questionnaire
rather than on the estimates, which were based on 12 daily diet
records over 1 year. The estimate of total energy was about 11%
higher by questionnaire than by the diet records.
In summary, our data support for the notion that soy intake
may be associated with risk of death from stomach cancer, either
because of its beneﬁcial effect on etiology or survival once stomach
cancer occurs. Given the limitations mentioned above and the
observational study design, this hypothesis remains tentative. In
addition, the reason for a lack of an inverse association for miso,
but not natto, is not clear. The potential effect of dietary soy on
stomach cancer warrants further study.
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